GovChime
Notice ID: 256915d8d0524d639ce846d2feefd189Special Notice

6505--F-18 Pylarify / Piflufolastat - Injectable Radiopharmaceutical Ann Arbor - Nuclear Medicine Brand Name Only

Archived on September 26, 2023. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
12:00 PM UTC−04:00
Posted
September 6, 2023
Notice type
Special Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
250-NETWORK CONTRACT OFFICE 10 (36C250)
Last updated
Dec 6, 2025

Identifiers

Solicitation number
36C25024Q0013
Notice ID
256915d8d0524d639ce846d2feefd189

Description

Description The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, located at 3140 Governor s Place Blvd., Suite 210, Kettering, OH 45409 intends to award a single-award, firm-fixed-priced FSS contract from 10/01/2023 until 09/30/2024 to Progenics Pharmaceuticals, Inc., a Lantheus company. A determination by the Government not to compete the proposed acquisition will be based upon responses of this notice, it is solely within the discretion of the Government. Inquiries shall be emailed to LouAnn.Gilliland@va.gov. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government in future procurements. The Progenics Pharmaceuticals, Inc. s address is at 331 Treble Cove Road, North Billerica, MA, 01862, United States. This award will be for the Nuclear Medicine Clinic at the Ann Arbor VAMC, Ann Arbor, MI 48105. The acquisition is conducted under authority of the Multiple Award Schedule Program; FAR Subpart 8.405-6(b) Items Peculiar to one Manufacturer. The primary statutory authorities for the MAS program are 41 U.S.C. 152(3), Competitive Procedures, and 40 U.S.C. 501, Service for Executive Agencies. It is the Government s belief the proposed candidate is the sole manufacturer capable of meeting the requirement. The associated North America Classification Systems (NAICS) Code is 325412 and the Small Business Size Standard is 1,300 employees. It is the Government s belief the proposed candidate is the only source with the required capabilities to successfully meet the requirement for PYLARIFY® (piflufolastat F 18) Injection, which is a radioactive diagnostic agent for men with prostate cancer. This is an FDA approved, proprietary item available only through the sole manufacturer and authorized supplier of PYLARIFY. This notice satisfies the requirement at FAR 5.201(b)(1), to publicize the proposed contract action. This notice of intent is not a request for competitive proposals. No solicitation documents are available at this time. Interested parties may give written notice to LouAnn.Gilliland@va.gov by 12:00pm e.s.t. on September 11, 2023. No telephone requests will be accepted.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36C25024Q0013
  1. Special NoticeCurrentSep 6, 2023

    6505--F-18 Pylarify / Piflufolastat - Injectable Radiopharmaceutical Ann Arbor - Nuclear Medicine Brand Name Only

    Notice 256915d8d0524d639ce846d2feefd189 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36C25024Q0013

Archive Date

Sep 26, 2023

Office Address

DAYTON, OH, 45428